The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma.
Cancer biology & therapy（2023）
Abstract
DEB-TACE displays attenuated hepatic fibrosis progression and noninferior tolerance compared to cTACE in treating intermediate- or advanced-stage HCC patients.
MoreTranslated text
Key words
Hepatocellular carcinoma,conventional transarterial chemoembolization,drug-eluting bead transarterial chemoembolization,hepatic fibrosis,safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined